Myeloma Today Spring 2018 Volume 18 Number 2 (https://www.myeloma.org/resource-library/myeloma-today-spring-2018-volume-18-number-2)
(https://s3.us-west-1.wasabisys.com/imf-d8-prod/2019-03/mt182_d2_web.pdf)
Dear Reader
- A message from IMF President Susie Novis
Scientific & Clinical
- Immunotherapy in Myeloma: Monoclonal Antibodies
- FDA Expands Approval of Xgeva in Patients with Myeloma
- Updates on Drug Therapies for Multiple Myeloma
Education & Awareness
- IMF Reaches Out to Community Healthcare Providers
Special Event
- 2018 Myeloma Action Month!
Member Events
- A 5K Walk to Support the Work That Wins the Battle
- There Is No Such Thing As a Drop in the Bucket
Advocacy
- Advocacy Team Gives Greater Voice to Myeloma Patients’ Needs
International Partners
- IMF Holds Another Successful Patient & Family Seminar in Italy
with support from:
Amgen, Celgene, Genentech, Janssen, and Takeda Oncology